Newsroom
Company news, product launches and press coverage from EClinCloud.
EClinCloud Supports the Successful Third 2025 Meeting of the China Quality Association for Pharmaceuticals CRO BranchOn September 21, the third 2025 meeting of the Clinical Trial Contract Research Organization Branch of the China Quality Association for Pharmaceuticals (abbreviated as the "CRO Branch"), co-hosted by EClinCloud, was successfully held in Chengdu. Senior executives from companies including R&G PharmaStudies and Guoxin Pharmaceutical, along with 42 representatives from 31 member organizations, gathered to discuss industry trends.
EClinCloud Invites You to Attend the "Patient-Centered Clinical Trial Design and Practice" SalonTo promote the development and exchange of the clinical trial industry, the Chengdu High-Tech Zone Bio-Industry Bureau has organized the 2025 GCP Thematic Salon Series. As an important stop in the series, the "Patient-Centered Clinical Trial Design and Practice" salon will be held in Chengdu on Tuesday afternoon, September 23. EClinCloud's Founder and CEO Dr. Qin Long has been invited to present "AI-Enabled eCOA/ePRO Clinical Research Practice." This salon will focus on trial design and risk management with clinically reported outcomes as endpoints, exploring the use of new technological approaches for patient-reported data collection and related practices. We welcome you to register at the end of this post to participate.
Regulatory Brief | Neuropathic Pain Clinical Trials to Receive Formal Technical GuidanceOn September 8, 2025, the Center for Drug Evaluation (CDE) issued a notice seeking public comment on the "Technical Guidelines for Clinical Trials of Drugs for Neuropathic Pain (Draft for Comment)." This marks an initial effort in China to issue systematic guidance in this field.
Hi, Meet EClinCloud's New Team Members and New Office!About EClinCloud: EClinCloud is a leading AI company in the clinical research industry. Powered by AI, it builds an integrated intelligent clinical cloud platform and endpoint assessment technologies, providing global pharmaceutical companies and research institutions with technology products including eCOA, CTMS, eTMF, EDC, RTSM, IRC, and RM, as well as scale management, linguistic validation, rater training, and data quality analysis services to deliver efficient, precise digital solutions. Leveraging AI predictive models and an intelligent data platform, it dynamically assesses and helps improve drug clinical trial success rates, helping shorten drug and device R&D cycles to benefit patients.
Unlock 177 Global Coordinates with EClinCloud eCOAEvery global expansion of clinical research is also a global extension of digital technology and services—EClinCloud eCOA's global "coordinates" map has been fully updated.